Table 11.
Extended version of EEG signal power metrics and their relationship to motor function or outcome in stroke
| Correlation with clinical measures | EEG metric | Severity | Stage | Age mean (std), [range] | Stroke type | M/F | # Sub | Year | Author | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|
| First noticeable electrical changes during stroke | Global alpha and beta power | NIHSS: 14(6.3) | Acute | 69.3(9.9) | IS | 11/7 | 18 | 2016 | Finnigan | [58] |
| 105-day FIM FA | Global alpha and beta power | NIHSS: 9(7.7) | Acute | 71(14) | IS | 13/12 | 25 | 2014 | Schleiger | [53] |
| 12-months NIHS | Global alpha and beta power | NIHSS: 14(9) | Acute | 67.4(11.9) | IS | 38/112 | 151 | 2018 | Bentes | [96] |
| 3-months mR | Delta power, Theta power | mRS: 2.7(1.1) | Acute | 65(10) | IS | 11/17 | 28 | 2007 | Cuspineda | [36] |
| Delayed Cerebal Ischemia (DCI) | Delta power, Theta power | NA | Acute | 55[18 82] | IS | 26/12 | 34 | 2004 | Claassen | [43] |
| 1-month NIHS | Delta power, Theta power | NIHSS: 16(9) | Acute | 74.5[55 87] | IS | 6/5 | 11 | 2004 | Finnigan | [52] |
| 30 and 90 days mBI and mRS | Delta power, Theta power | NIHSS: 6.5(6.4) | Acute | 65.7(17) | IS(12) and HS(4) | 7/9 | 16 | 2020 | Rogers | [121] |
| 6-months mR | DTR, DAR, DTABR | NA | Acute | 75[24.5 89] | IS | 55/55 | 110 | 2011 | Sheorajpanday | [105] |
| 90-days MoC | DTR, DAR, DTABR | NIHSS: 5.7(6.2), mRS: 1.9(1.4) | Acute | 65.95(15.78) | IS(15) and HS (4) | 12/7 | 19 | 2017 | Aminov | [54] |
| NIHSS evolution 3 weeks to 6-mont | DTR, DAR, DTABR | NIHSS: 5 [3.5 7.5] | Acute- Subacute | 67(11) | IS | 17/24 | 41 | 2020 | Saes | [120] |
| 2-months FMUE | BSI, pdBSI | NIHSS: 13 | Chronic | 61 [37 81] | IS | 9/11 | 20 | 2013 | Dubovik | [104] |
| 6-months mR | BSI, pdBSI | NIHSS: 2.4(2.5), FMUE: 43(22) | Chronic | 60.6 [48 77] | IS | 6/15 | 21 | 2019 | Saes | [125] |
| WMFT and FM | Global alpha and beta power | mild to moderate paresis | Chronic | 59.5(13) | NA | 3/1 | 14 | 2018 | Bertolucci | [47] |
| shape and delay of ERD-ERS | Global alpha and beta power | barthel: 11, FIM: 60 | sub acute | 75 | NA | 0/1 | 1 | 2015 | Comani | [101] |
| motor therapy gain | Global delta | Chronic: 8, subacute: 29 | Chronic and sub acute | 56 and 75 | IS | 1/1 | 2 | 2015 | Sale P | [122] |
| theta band BSI predictors 6-months FM-UE | BSI | FMUE: 21, ARAT: 3.5 | Acute, Subacute | 67.3(11.4) | IS | 16/23 | 39 | 2021 | Saes | [124] |
| FMUE change | DAR, DTABR | FMUE: 42(17) | Chronic | 55.7(16) | IS (8) and HS (2) | 2/8 | 10 | 2017 | Trujillo | [99] |
IS ischemic stroke, HS hemorrhagic stroke, M male, F female